T1	PROC 48 78	Ensayo clínico abierto, fase I
T2	Dose 158 173	dosis repetidas
T3	LIVB 212 217	niños
#1	AnnotatorNotes T3	C0008059; Child; Age Group | C0870221; Boys; Age Group
T4	Age 212 217	niños
T5	LIVB 220 232	adolescentes
#2	AnnotatorNotes T5	C0205653; Adolescent (age group); Age Group
T6	Age 220 232	adolescentes
T7	DISO 284 293	Epilepsia
#3	AnnotatorNotes T7	C0014544; Epilepsy; Disease or Syndrome
T8	DISO 363 387	encefalitis de Rasmussen
#4	AnnotatorNotes T8	C0393484; Rasmussen Syndrome; Disease or Syndrome
T9	PROC 432 456	consentimiento informado
#5	AnnotatorNotes T9	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T10	LIVB 461 481	Población pediátrica
T11	Age 482 498	menor de 16 años
T12	PROC 574 585	tratamiento
#6	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	CHEM 587 611	fármacos antiepilépticos
T14	PROC 614 638	terapia inmunomoduladora
T15	DISO 679 708	deterioro motor y/o cognitivo
T16	PROC 766 786	cirugía de epilepsia
T17	DISO 809 833	Encefalitis de Rasmussen
#7	AnnotatorNotes T17	C0393484; Rasmussen Syndrome; Disease or Syndrome
T18	PROC 868 871	RMC
#8	AnnotatorNotes T18	C0412692; Magnetic Resonance Imaging (MRI) of Heart; Diagnostic Procedure | C4028269; Nuclear magnetic resonance imaging brain; Diagnostic Procedure
T19	PROC 873 900	pruebas electrofisiológicas
T20	PROC 902 905	PET
#9	AnnotatorNotes T20	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T21	PROC 908 938	evaluaciones neuropsicológicas
T22	Spec_cue 1000 1006	pueden
T23	Speculated 1007 1014	afectar
T24	LIVB 1032 1040	paciente
#10	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T25	DISO 1064 1104	Infecciones activas del SNC o sistémicas
T26	DISO 1115 1120	Tumor
#11	AnnotatorNotes T26	C0027651; Neoplasms; Neoplastic Process | C0038999; Swelling; Finding
T27	PROC 1130 1143	Quimioterapia
#12	AnnotatorNotes T27	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T28	DISO 1153 1172	Enfermedad cardíaca
#13	AnnotatorNotes T28	C0018799; Heart Diseases; Disease or Syndrome
T29	DISO 1175 1183	Demencia
#14	AnnotatorNotes T29	C0497327; Dementia; Mental or Behavioral Dysfunction
T30	DISO 1191 1222	enfermedad degenerativa del SNC
T31	PROC 1259 1291	cateterismo del sistema arterial
T32	Contraindicated 1259 1291	cateterismo del sistema arterial
T33	Neg_cue 1314 1316	no
T34	Negated 1321 1329	factible
T35	DISO 1343 1371	trastornos de comportamiento
#15	AnnotatorNotes T35	C0004930; Behavior Disorders; Mental or Behavioral Dysfunction
T36	Neg_cue 1376 1383	impiden
T37	Negated 1388 1400	colaboración
T38	PROC 1437 1462	parámetros de coagulación
T39	Neg_cue 1529 1531	no
T40	DISO 1602 1621	reacciones adversas
#16	AnnotatorNotes T40	C0559546; Adverse reactions; Pathologic Function
T41	DISO 1624 1654	complicaciones tromboembólicas
T42	CHEM 1671 1695	componentes de la sangre
T43	PHYS 1701 1709	Embarazo
#17	AnnotatorNotes T43	C0032961; Pregnancy; Organism Function
T44	PHYS 1723 1732	lactancia
#18	AnnotatorNotes T44	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T45	Neg_cue 1737 1745	Negativa
T46	LIVB 1750 1758	paciente
#19	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 1761 1771	familiares
#20	AnnotatorNotes T47	C0080103; Relative (related person); Family Group
T48	PROC 1777 1788	seguimiento
#21	AnnotatorNotes T48	C0420316; Other follow-up; Health Care Activity
T49	Negated 1777 1788	seguimiento
T50	PROC 1419 1434	acceso arterial
T51	Speculated 1419 1434	acceso arterial
T52	Speculated 1437 1462	parámetros de coagulación
T53	Route 140 154	intra-arterial
T54	CHEM 177 208	células mesenquimales autólogas
T55	PROC 1542 1576	administrar productos terapéuticos
T56	Negated 1542 1576	administrar productos terapéuticos
T57	DISO 969 981	Enfermedades
T58	Age 471 481	pediátrica
T59	DISO 318 327	Epilepsia
T60	DISO 237 247	epilepsias
T61	DISO 503 512	Epilepsia
T62	PROC 84 124	evaluar la seguridad y respuesta clínica
T63	LIVB 713 718	grupo
T64	PROC 131 154	infusión intra-arterial
T65	Observation 107 124	respuesta clínica
T66	Quantifier_or_Qualifier 199 208	autólogas
T67	Quantifier_or_Qualifier 248 260	refractarias
T68	Observation 533 544	refractaria
T69	Quantifier_or_Qualifier 547 570	primera o segunda línea
T70	Observation 1007 1027	afectar la seguridad
T71	Quantifier_or_Qualifier 1105 1112	activas
T72	Quantifier_or_Qualifier 1121 1127	activo
T73	Quantifier_or_Qualifier 1144 1150	activa
T74	Quantifier_or_Qualifier 1331 1342	importantes
T75	Observation 1388 1409	colaboración adecuada
T76	Observation 1411 1434	difícil acceso arterial
T77	Quantifier_or_Qualifier 1463 1486	clínicamente relevantes
T78	Patient 212 217	niños
T79	Patient 220 232	adolescentes
T80	Patient 461 481	Población pediátrica
T81	Future 766 786	cirugía de epilepsia
T82	Patient 1032 1040	paciente
T83	History_of 1602 1621	reacciones adversas
T84	History_of 1624 1654	complicaciones tromboembólicas
T85	Patient 1750 1758	paciente
T86	Family_member 1761 1771	familiares
